CAS 926927-61-9

VTX-2337

Description:

VTX-2337, with the CAS number 926927-61-9, is a small molecule that has been investigated primarily for its potential therapeutic applications in oncology and immunology. It functions as a toll-like receptor 8 (TLR8) agonist, which means it can stimulate the immune system by activating TLR8, a receptor that plays a crucial role in the innate immune response. This activation can enhance the body's ability to recognize and fight cancer cells and may also have implications in treating viral infections. VTX-2337 is characterized by its ability to induce cytokine production, which can lead to an improved immune response. The compound has been studied in various preclinical and clinical settings to evaluate its efficacy and safety profile. Its chemical structure and properties contribute to its biological activity, making it a subject of interest in drug development aimed at harnessing the immune system for therapeutic benefits. Further research is ongoing to fully understand its mechanisms and potential applications in clinical practice.

Synonyms:

• Motolimod

2-Amino-N,N-dipropyl-8-[4-(1-pyrrolidinylcarbonyl)phenyl]-3H-1-benzazepine-4-carboxamide

CAS: 926927-61-9

Formula: C₂₈H₃₄N₄O₂

Purity: 99%

Color and Shape: Solid

Molecular weight: 458.5952

Ref: IN-DA003A8G

2-Amino-N,N-Dipropyl-8-(4-(Pyrrolidine-1-Carbonyl)Phenyl)-3H-Benzo[B]Azepine-4-Carboxamide

CAS: 926927-61-9

2-Amino-N,N-Dipropyl-8-(4-(Pyrrolidine-1-Carbonyl)Phenyl)-3H-Benzo[B]Azepine-4-Carboxamide

Purity: 98%

Molecular weight: 458.6g/mol

Ref: 54-OR1023811

Motolimod

CAS: 926927-61-9

Motolimod

Purity: ≥95%

Molecular weight: 458.6g/mol

Ref: 54-BUP07739

Motolimod

CAS: 926927-61-9

Motolimod (VTX-378) (VTX-2337) is an effective and specific Toll-like receptor (TLR) 8 agonist (EC50: 100 nM), > 50-fold selectivity over TLR7.

Formula: C₂₈H₃₄N₄O₂

Purity: 97.43% - 99.66%

Color and Shape: Solid

Molecular weight: 458.6

Ref: TM-T6898